NCT00981591 - Inhaled Iloprost as an Adjunct to Inhaled Nitric Oxide in Pediatric Critical Care Patients | Biotech Hunter

Timeline

Start Date

September 30, 2009

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions

Pulmonary HypertensionNeonatal Hypoxic Respiratory FailurePersistent Pulmonary Hypertension of NewbornCongenital Heart DefectsAcute Respiratory Distress Syndrome

Interventions

DRUG

Iloprost

Inhaled via Aerogen nebulizer, 0.5 mcg/kg every 2 hours; uptitrated to effect, to maximum dose of 30 mcg every 30 minutes

DRUG

Placebo

Inhaled via Aerogen nebulizer, 0.5 mcg/kg every 2 hours or more